Anson Funds Management’s Korro Bio KRRO Stock Holding History

Anson Funds Management’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-851	Closed	-$218K	–	394
2021 Q4	$218K	Buy	+851	New	+$259K	0.02%	300

Other funds holding KRRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Anson Funds Management's KRRO Position: Q1 2022 in Review

Anson Funds Management sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 851 shares — an estimated $218K sold.

Anson Funds Management first reported a position in KRRO in Q4 2021 and held it in 1 quarter. The position peaked at $218K in Q4 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

Anson Funds Management reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
Anson Funds Management sold 851 Korro Bio shares in Q1 2022, an estimated $218K.
Anson Funds Management first reported a position in Korro Bio in Q4 2021 and held it in 1 quarter.
Anson Funds Management's Korro Bio position peaked at $218K in Q4 2021.
85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.